Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia-Reference-Cited by-同舟云学术

Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia

Published:2017-10-03 Issue:1 Volume:36 Page:366-369
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Visentin Andrea¹²^ORCID,Briani Chiara³,Imbergamo Silvia¹,Frezzato Federica¹²^ORCID,Angelini Annalisa⁴,Fedrigo Marny⁴,Cacciavillani Mario⁵,Altinier Sara⁶,Piazza Francesco¹²,Semenzato Gianpietro¹²,Adami Fausto¹,Trentin Livio¹²^ORCID

Affiliation:

1. Hematology and Clinical Immunology Unit, Department of Medicine; University of Padua; Padua Italy

2. Venetian Institute of Molecular Medicine; Centro di Eccellenza per la Ricerca Biomedica Avanzata; Padua Italy

3. Neurology Unit, Department of Neuroscience; University of Padua; Padua Italy

4. General Pathology and Cytopathology Unit, Department of Medicine; University of Padua; Padua Italy

5. CEMS-EMG Lab; Data Medica Group; Padua Italy

6. Laboratory Medicine Unit, Department of Medicine; University of Padua; Padua Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference12 articles.

1. A case of chronic lymphocytic leukemia associated with systemic light chain amyloidosis;Wong;Leuk Lymphoma,2013

2. Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature review;Dou;Diagn Pathol,2011

3. Amyloidosis associated with chronic lymphocytic leukemia;Ikee;Amyloid,2005

4. Integrated CLL scoring system, a new and simple index to predict time to treatment and overall survival in patients with chronic lymphocytic leukemia;Visentin;Clin Lymphoma Myeloma Leuk,2015

5. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness;Rossi;Clin Cancer Res: an official journal of the American Association for Cancer Research,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance;Cancers;2022-03-18

2. Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies;Brain Sciences;2021-01-20

3. From pathogenesis to personalized treatments of neuropathies in hematological malignancies;Journal of the Peripheral Nervous System;2020-08-07

4. Educational Case: Orbital B-Cell Lymphoma With Amyloid Deposition;Academic Pathology;2020-01-01

5. Peripheral nervous system involvement in lymphomas;Journal of the Peripheral Nervous System;2019-01-08